Clinical Trial Update: Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a KLH-conjugated pentavalent vaccine targeting GD2L, GD3L, Globo H, Fucosyl GM1, and N-propionylated polysialic acid in lung cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• KLH-conjugated pentavalent cancer vaccine (GD2L, GD3L, Globo H, Fucosyl GM1, and N-propionylated polysialic acid) (KLH-conjugated pentavalent vaccine targeting GD2L, GD3L, Globo H, Fucosyl GM1, and N-propionylated polysialic acid)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED